Skip to content

Comparison Between Erector Spinae Plane Block and Transversus Abdominis Plane Block on Postoperative Analgesia After Total Abdominal Hysterectomy

Comparative Study Between Bilateral Ultrasound-Guided Erector Spinae Plane Block Versus Bilateral Ultrasound-Guided Transversus Abdominis Plane Block on Postoperative Analgesia After Total Abdominal Hysterectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05533710
Enrollment
40
Registered
2022-09-09
Start date
2021-08-28
Completion date
2023-08-31
Last updated
2022-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Diseases

Keywords

ESPB, TAP

Brief summary

This study aims to compare the ultrasound-guided bilateral erector spinae block versus the ultrasound-guided bilateral transversus abdominis plane block on postoperative analgesia after total abdominal hysterectomy.

Interventions

PROCEDUREerector spinae plane block

Patients will receive ESB. In the lateral decubitus, after skin sterilization, ESP block will be performed at the level of T9

PROCEDUREtransversus abdominis plane block

patients will receive TAP block in supine position after skin sterilization, TAP block will be performed between internal oblique and transversus abdominis muscles

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Patients American Society of Anesthesiologists physical status (ASA) I and II. 2. Female sex. 3. Age between 40 to 60 years old. 4. Scheduled for elective total abdominal hysterectomy surgeries.

Exclusion criteria

1. Patient's refusal. 2. Patients who received long-acting opioids preoperatively. 3. Patients with bleeding disorders and coagulopathy. 4. Infection at the injection site. 5. Allergy to local anesthetics. 6. Patients with significant cognitive dysfunction. 7. Patients with diabetic neuropathy. 8. Patients with uncontrolled hypertension or diabetes. 9. Patients with advanced cardiac, respiratory, hepatic or renal disease. 10. Patients with viral hepatitis or HIV. 11. Surgeries which have been complicated or prolonged (more than 150 mins).

Design outcomes

Primary

MeasureTime frameDescription
Total morphine consumption24 hours postoperativeCompare postoperative pain intensity using the total amount of morphine consumption in the first 24 hours after the operation, and the time for first call rescue analgesia
Visual Analog Scale Score24 hours postoperativeCompare postoperative pain intensity using VAS score in the first 24 hours after the operation.The VAS score is a 10-cm line labeled with worst pain imaginable on the right border, and no pain on the left border (ranging from 0 by indicating no pain to 10 indicating extreme pain).
The time for first call rescue analgesia24 hours postoperativethe time for first call rescue analgesia

Secondary

MeasureTime frameDescription
Patient satisfaction24 hours postoperativeMeasure patient satisfaction by asking the patient if he is satisfied or not yes or no
Recognize the adverse effects24 hours postoperativeRecognize the adverse effects

Countries

Egypt

Contacts

Primary Contactisraa ihab, MSc
israa_ihab@med.asu.edu.eg01005461696

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026